LV12539B - EDIBLE 4-OXY-NAFTIRIDINE-3-CARBOXAMES AS A GAS HEAD-BAND RECEPTOR - Google Patents

EDIBLE 4-OXY-NAFTIRIDINE-3-CARBOXAMES AS A GAS HEAD-BAND RECEPTOR Download PDF

Info

Publication number
LV12539B
LV12539B LVP-00-29A LV000029A LV12539B LV 12539 B LV12539 B LV 12539B LV 000029 A LV000029 A LV 000029A LV 12539 B LV12539 B LV 12539B
Authority
LV
Latvia
Prior art keywords
carboxamide
naphthyridine
tetrahydro
compound
oxy
Prior art date
Application number
LVP-00-29A
Other languages
English (en)
Latvian (lv)
Other versions
LV12539A (en
Inventor
Pamela Albaugh
Robert W. Desimone
Gang Liu
Original Assignee
Neurogen Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corporation filed Critical Neurogen Corporation
Publication of LV12539A publication Critical patent/LV12539A/xx
Publication of LV12539B publication Critical patent/LV12539B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
LVP-00-29A 1997-08-25 2000-03-16 EDIBLE 4-OXY-NAFTIRIDINE-3-CARBOXAMES AS A GAS HEAD-BAND RECEPTOR LV12539B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91818097A 1997-08-25 1997-08-25
PCT/US1998/017513 WO1999010347A1 (en) 1997-08-25 1998-08-24 Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands

Publications (2)

Publication Number Publication Date
LV12539A LV12539A (en) 2000-10-20
LV12539B true LV12539B (en) 2001-01-20

Family

ID=25439933

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-00-29A LV12539B (en) 1997-08-25 2000-03-16 EDIBLE 4-OXY-NAFTIRIDINE-3-CARBOXAMES AS A GAS HEAD-BAND RECEPTOR

Country Status (24)

Country Link
EP (1) EP1007526A1 (sh)
JP (1) JP2001514181A (sh)
KR (1) KR20010023313A (sh)
CN (1) CN1268136A (sh)
AP (1) AP2000001742A0 (sh)
AU (1) AU753800B2 (sh)
BG (1) BG104192A (sh)
BR (1) BR9811362A (sh)
CA (1) CA2301599C (sh)
EG (1) EG21717A (sh)
HU (1) HUP0003258A3 (sh)
IL (1) IL134291A0 (sh)
IS (1) IS5382A (sh)
LV (1) LV12539B (sh)
NO (1) NO20000822L (sh)
NZ (1) NZ502548A (sh)
OA (1) OA11293A (sh)
PE (1) PE130999A1 (sh)
PL (1) PL338783A1 (sh)
SI (1) SI20270A (sh)
SK (1) SK2162000A3 (sh)
TW (1) TW574221B (sh)
WO (1) WO1999010347A1 (sh)
YU (1) YU10500A (sh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413956B1 (en) * 1999-05-06 2002-07-02 Neurogen Corporation Substituted 4-oxo-quinoline-3-carboxamides
WO2000071528A1 (en) * 1999-05-25 2000-11-30 Neurogen Corporation 4h-1,4-benzothiazine-2-carboxamides and their use as gaba brain receptor ligands
US6562822B2 (en) 2000-07-12 2003-05-13 Pharmacia & Upjohn Company Heterocyle carboxamides as antiviral agents
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
IL155089A0 (en) 2000-10-12 2003-10-31 Merck & Co Inc Aza and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
DE60128936T2 (de) 2000-10-12 2008-04-10 Merck & Co, Inc. Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
US6841558B2 (en) 2000-10-12 2005-01-11 Merck & Co., Inc. Aza-and polyaza-naphthalenyl carboxamides useful as HIV intergrase inhibitors
US20020151591A1 (en) * 2000-10-17 2002-10-17 Anabella Villalobos Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders
CN1494422A (zh) * 2001-03-01 2004-05-05 �Ʒ� Gabaa反相激动剂与烟碱受体不完全激动剂、雌激素、选择性雌激素调节剂、或维生素e联合用于认知障碍的用途
AR036256A1 (es) 2001-08-17 2004-08-25 Merck & Co Inc Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento
AU2003216049B2 (en) 2002-01-17 2008-07-17 Merck Sharp & Dohme Corp. Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors
US7323460B2 (en) 2002-03-15 2008-01-29 Merck & Co., Inc. N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as HIV integrase inhibitors
WO2004106336A1 (en) * 2003-05-27 2004-12-09 Pfizer Products Inc. Process for the preparation and purification of 1,5-naphthyridine-3-carboxyamides
WO2004106334A2 (en) * 2003-05-28 2004-12-09 Pfizer Products Inc. Process for the preparation of 1,5-naphthyridine-3-carboxy amides by direct ester amidation
CA2666219C (en) * 2006-10-16 2017-02-07 Bionomics Limited Novel anxiolytic compounds
CA2670116C (en) * 2006-11-22 2015-03-10 Seaside Therapeutics, Llc Methods of treating mental retardation, down's syndrome, fragile x syndrome and autism

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204162A1 (es) * 1972-05-08 1975-11-28 Yamanouchi Pharma Co Ltd Proceso para la preparacion de derivados de ampicilina
GB1433774A (en) * 1973-02-26 1976-04-28 Allen & Hanburys Ltd Heterocyclic compounds apparatus for conveying articles
US4374138A (en) * 1981-11-13 1983-02-15 Warner-Lambert Company Antibacterial amide compounds, compositions, and methods of use
DD279887A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von d-alpha-(4(1h)-1,5-naphthyridon-3-carboxamido)-benzylpenicillin und anderen beta-lactamantibiotika
DD279875A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von aktivierten carbonsaeureestern
DD295360A5 (de) * 1987-07-03 1991-10-31 Akad Wissenschaften Verfahren zur Herstellung von aktivierten Carbonsäureestern
JPS6461461A (en) * 1987-09-01 1989-03-08 Otsuka Pharma Co Ltd Benzohetero ring derivative

Also Published As

Publication number Publication date
YU10500A (sh) 2002-10-18
NO20000822D0 (no) 2000-02-18
JP2001514181A (ja) 2001-09-11
NO20000822L (no) 2000-04-13
AP2000001742A0 (en) 2000-02-24
NZ502548A (en) 2002-06-28
EP1007526A1 (en) 2000-06-14
HUP0003258A3 (en) 2001-05-28
HUP0003258A2 (en) 2001-03-28
AU753800B2 (en) 2002-10-31
AU9117398A (en) 1999-03-16
IL134291A0 (en) 2001-04-30
SI20270A (sl) 2000-12-31
BR9811362A (pt) 2000-08-22
PL338783A1 (en) 2000-11-20
IS5382A (is) 2000-02-22
SK2162000A3 (en) 2001-03-12
OA11293A (en) 2002-11-19
WO1999010347A1 (en) 1999-03-04
CA2301599C (en) 2003-03-25
LV12539A (en) 2000-10-20
CN1268136A (zh) 2000-09-27
TW574221B (en) 2004-02-01
BG104192A (en) 2001-05-31
CA2301599A1 (en) 1999-03-04
PE130999A1 (es) 1999-12-16
EG21717A (en) 2002-02-27
KR20010023313A (ko) 2001-03-26

Similar Documents

Publication Publication Date Title
US6646124B2 (en) Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligands
US6380209B1 (en) 4-(4-piperidylmethylamino) substituted heteroaryl fused pyridines: GABA brain receptor ligands
LV12539B (en) EDIBLE 4-OXY-NAFTIRIDINE-3-CARBOXAMES AS A GAS HEAD-BAND RECEPTOR
US6166203A (en) Heterocyclic amino substituted heteroaryl fused pyridines; GABA brain receptor ligands
AU2001280667B2 (en) Capsaicin receptor ligands
US6414147B1 (en) 2-amino-9-alkylpurines: GABA brain receptor ligands
US5185446A (en) Certain cycloalkyl imidazopyrimidines; a new class of gaba brainreceptor ligands
WO1999043660A1 (en) Substituted 1,4-dihydro-4-oxonicotinic carboxamides: gaba brain receptor ligands
US6177569B1 (en) Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
US6194427B1 (en) Substituted cycloalkyl-4-Oxonicotinic carboxamides; gaba brain receptor ligands
US6297252B1 (en) Imidazo[1,5-c]quinazolines; A new class of GABA brain receptor ligands
US5463054A (en) Certain aryl fused pyrrolopyrimidines; a new class of GABA brain receptor ligands
EP1107966B1 (en) Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands
MXPA00001598A (en) Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands
MXPA00008364A (en) Substituted cycloalkyl-4-oxonicotinic carboxamides;gaba brain receptor ligands
MXPA01001991A (en) Oxo-pyridoimidazole-carboxamides:gaba brain receptor ligands